Human serum albumin-bound paclitaxel nanoparticle inhibits cervical carcinoma cell proliferation and oxidative damage through CYP3A4 and CYP2C8
Article in Heliyon (January 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial
Article in BMJ Open (May 2023)
Image Guidance Volume-Modulated Arc Radiation Therapy Concurrently With Nab-Paclitaxel Plus Cisplatin for Patients With Locally Advanced Cervical Cancer: A Single-Arm Dose Escalation Trial
Article in International Journal of Radiation Oncology • Biology • Physics (November 2022)